Characterization of the Mechanisms of Resistance to Azacitidine — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Characterization of the Mechanisms of Resistance to Azacitidine — Stella

Home/Myelodysplastic Syndromes or Acute Myeloid Leukemia With Multilineage Dysplasia/

View on ClinicalTrials.gov

Recruiting

Back to Myelodysplastic Syndromes or Acute Myeloid Leukemia With Multilineage Dysplasia trials

Trial locations(4 sites)

France

CH d'Antibes, Antibes

CHU de Nice - Hôpital de l'Archet, Nice

Centre Antoine Lacassagne, Nice

Monaco

CH Princesse Grace, Monaco

Key details

Sponsor

Centre Hospitalier Universitaire de Nice

Enrollment target

~250 participants

Started

September 2010

Primary completion

September 2014

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.